NEJM January 12, 2021
The pharma industry came together under extraordinary circumstances to develop a vaccine for Covid-19. Biotech and AI will play a major role in what’s to come next.
Jeremy Levin, CEO of Ovid Therapeutics and Chairman of the Biotechnology Innovation Organization, and Evelyne Bischof, Associate Professor at the Shanghai University School of Medicine and Health Sciences and a researcher at University Hospital in Basel, Switzerland, discuss the complexity of vaccine development for Covid-19, and what it can teach us for the future of vaccines, both as clinicians and patients.
Edward Prewitt, MPP, Editorial Director for NEJM Catalyst, interviews Jeremy Levin, CEO of Ovid Therapeutics...